NASDAQ:BTAI | Operating Income | BioXcel Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2017-03-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$10.19M
2026-03-31-$10.22M
2025-12-31-$10.28M
2025-09-30-$14.23M
2025-06-30-$15.85M
2025-03-31-$10.1M
2024-12-31-$10.49M
2024-09-30-$15.29M
2024-06-30-$17.3M
2024-03-31-$24.16M
2023-12-31-$19.88M
2023-09-30-$48.3M
2023-06-30-$52.41M
2023-03-31-$51.2M
2022-12-31-$52.89M
2022-09-30-$38.99M
2022-06-30-$36.29M
2022-03-31-$31.48M
2021-12-31-$26.13M
2021-09-30-$26.81M
2021-06-30-$27.61M
2021-03-31-$26.38M
2020-12-31-$21.1M
2020-09-30-$24.77M
2020-06-30-$21.44M
2020-03-31-$15M
2019-12-31-$8.41M
2019-09-30-$9.13M
2019-06-30-$8.64M
2019-03-31-$7.42M
2018-12-31-$7.31M
2018-09-30-$5.12M
2018-06-30-$3.24M
2018-03-31-$4.29M
2017-12-31-$2.53M
2017-09-30-$917,000.00
2017-06-30-$565,000.00
2017-03-31-$529,000.00

Annual Operating Income

DateOperating Income
2025-12-31-$50.46M
2024-12-31-$67.25M
2023-12-31-$171.78M
2022-12-31-$159.65M
2021-12-31-$106.94M
2020-12-31-$82.3M
2019-12-31-$33.6M
2018-12-31-$19.96M
2017-12-31-$4.54M